MBLY Stock Jumps As Earnings Beat Fuels Short-Squeeze Hype

TIM BOHENUPDATED APR. 24, 2026, 12:35 PM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

Mobileye Global Inc. stocks have been trading up by 8.91 percent following upbeat sentiment around its autonomous driving technology advancements.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading MBLY

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

  • Q1 2026 revenue hit $558M, up 27% year over year and ahead of the $519.9M Street view, with adjusted EPS at $0.12 versus $0.08–$0.09 expected.
  • Full‑year 2026 revenue guidance was raised to roughly $1.94B–$2.02B, topping prior consensus near $1.95B, alongside a higher adjusted operating income outlook.
  • A non‑cash $3.8B goodwill impairment tied to Intel’s past deal drove a large GAAP loss but did not change MBLY’s cash flow or operating trends.
  • A new $250M Class A share repurchase plan aims to offset dilution from stock‑based pay and the Mentee Robotics acquisition.
  • Analysts at Goldman Sachs, CFRA, and others lifted EPS expectations and highlighted future growth from higher‑value ADAS, hands‑free, robo‑taxi, and Drive platform programs.

Candlestick Chart

Live Update At 12:34:52 EDT: On Friday, April 24, 2026 Mobileye Global Inc. stock [NASDAQ: MBLY] is trending up by 8.91%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

MBLY has quietly shifted from grind mode to momentum mode on the chart. In late March, Mobileye Global Inc. was closing around $6.56–$6.87. By 2026/04/24, MBLY finished near $9.48 after a strong post‑earnings push. That is a powerful multi‑week trend for a large‑cap auto‑tech name.

The daily chart shows a steady stair‑step pattern: higher lows from about $6.50 to the mid‑$7s, then a sharp ramp into the high‑$8s and low‑$9s as traders reacted to the Q1 beat and guidance hike. Intraday, MBLY has been coiling between roughly $9.20 and $9.50, holding its gap and building a base instead of giving it all back. That tells traders dip‑buyers are still active.

More Breaking News

Under the hood, MBLY generated $1.894B in trailing revenue with a fat 47.7% gross margin but negative reported profit margins thanks to the goodwill hit. Free cash flow of about $45M last quarter, a current ratio above 6, and zero debt to equity point to a cash‑rich, low‑stress balance sheet. For short‑term trading, the key takeaway is clear: strong top‑line growth, clean liquidity, and a chart that just confirmed a breakout.

Why Traders Are Watching MBLY Right Now

MBLY is front and center on many trading screens because the fundamentals and the tape are finally lining up. Mobileye Global Inc. crushed Q1 expectations, printing $0.12 in adjusted EPS versus $0.08–$0.09 expected, powered by 27% revenue growth and strong EyeQ chip shipments. At the same time, management raised 2026 revenue guidance to roughly $1.94B–$2.02B and lifted its adjusted operating income outlook. That is a classic “beat and raise” setup.

Yet the headline number on standard earnings feeds was a massive loss, driven by a $3.8B non‑cash goodwill impairment tied to Intel’s 2017 acquisition and the 2022 spin. For traders who do not read footnotes, that looks ugly. For those who do the work, it is legacy accounting noise that does not touch MBLY’s cash.

The market seems to be siding with the second group. MBLY ripped more than 13% in premarket trading after the report and has held most of those gains. The company also approved a $250M buyback, mainly to neutralize dilution from stock‑based compensation and the Mentee Robotics deal. Add in a strong net cash position and elevated short interest, and you get real short‑squeeze fuel.

On the growth side, Mobileye Global Inc. is stacking catalysts: design wins with Mahindra, progress on VW Group robotaxis and advanced L2++/L3 programs, and the physical‑AI angle via Mentee Robotics. CFRA calls sentiment “overly bearish” and still rates MBLY a Buy, while Deutsche Bank keeps a Buy even after trimming its target. Goldman Sachs nudged its target to $9 and stays Neutral, a sign that not every analyst is convinced but the trend is improving. For active traders, this mix of skepticism and improving execution is exactly what you want for multi‑day momentum.

Conclusion

MBLY’s Q1 print shows the split personality of modern earnings season. On one side, Mobileye Global Inc. booked a giant GAAP loss because of a goodwill write‑down that traces back to Intel. On the other, the operating business is growing fast, with 27% revenue growth, higher underlying margins, and guidance that now sits above where the Street was modeling. Cash flow is positive, the balance sheet is strong, and a $250M repurchase plan adds another bid under the stock.

For traders, the lesson is to look past the scary headline numbers and focus on how price reacts. MBLY blasted higher on heavy volume and has been consolidating near the top of its range instead of unwinding. That behavior, combined with high short interest and a supportive analyst backdrop from firms like CFRA and Deutsche Bank, keeps Mobileye Global Inc. squarely in play.

This is not a call to buy or sell MBLY. It is a case study in how real catalysts, clean charts, and misunderstood accounting can create opportunity. As Tim Sykes likes to say, “Patterns repeat, but you have to be prepared.” And as Tim Bohen, lead trainer with StocksToTrade says, “Time and experience have taught me that missed opportunities are part of the game. There’s always another setup around the corner.” Mobileye Global Inc. is giving traders a live example of that idea, right on the screen, in real time.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.



The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders